477 related articles for article (PubMed ID: 34209586)
1. NLRP3 and Infections: β-Amyloid in Inflammasome beyond Neurodegeneration.
Sita G; Graziosi A; Hrelia P; Morroni F
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209586
[TBL] [Abstract][Full Text] [Related]
2. Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 transgenic mice.
Feng J; Wang JX; Du YH; Liu Y; Zhang W; Chen JF; Liu YJ; Zheng M; Wang KJ; He GQ
CNS Neurosci Ther; 2018 Dec; 24(12):1207-1218. PubMed ID: 29869390
[TBL] [Abstract][Full Text] [Related]
3. A Novel Inhibitor Targeting NLRP3 Inflammasome Reduces Neuropathology and Improves Cognitive Function in Alzheimer's Disease Transgenic Mice.
Kuwar R; Rolfe A; Di L; Blevins H; Xu Y; Sun X; Bloom GS; Zhang S; Sun D
J Alzheimers Dis; 2021; 82(4):1769-1783. PubMed ID: 34219728
[TBL] [Abstract][Full Text] [Related]
4. Soluble Aβ oligomers and protofibrils induce NLRP3 inflammasome activation in microglia.
Lučiūnaitė A; McManus RM; Jankunec M; Rácz I; Dansokho C; Dalgėdienė I; Schwartz S; Brosseron F; Heneka MT
J Neurochem; 2020 Dec; 155(6):650-661. PubMed ID: 31872431
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of NLRP3 Inflammasome Activation: Its Role in the Treatment of Alzheimer's Disease.
Zhang Y; Zhao Y; Zhang J; Yang G
Neurochem Res; 2020 Nov; 45(11):2560-2572. PubMed ID: 32929691
[TBL] [Abstract][Full Text] [Related]
6. Co-Localization of Glia Maturation Factor with NLRP3 Inflammasome and Autophagosome Markers in Human Alzheimer's Disease Brain.
Ahmed ME; Iyer S; Thangavel R; Kempuraj D; Selvakumar GP; Raikwar SP; Zaheer S; Zaheer A
J Alzheimers Dis; 2017; 60(3):1143-1160. PubMed ID: 28984607
[TBL] [Abstract][Full Text] [Related]
7. Microglial TLR4/NLRP3 Inflammasome Signaling in Alzheimer's Disease.
Li Y; Chen X; Zhou M; Feng S; Peng X; Wang Y
J Alzheimers Dis; 2024; 97(1):75-88. PubMed ID: 38043010
[TBL] [Abstract][Full Text] [Related]
8. TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer's Disease.
Yang J; Wise L; Fukuchi KI
Front Immunol; 2020; 11():724. PubMed ID: 32391019
[TBL] [Abstract][Full Text] [Related]
9. Beta-amyloid activates NLRP3 inflammasome via TLR4 in mouse microglia.
Liu Y; Dai Y; Li Q; Chen C; Chen H; Song Y; Hua F; Zhang Z
Neurosci Lett; 2020 Sep; 736():135279. PubMed ID: 32726591
[TBL] [Abstract][Full Text] [Related]
10. Aggregated Tau activates NLRP3-ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo.
Stancu IC; Cremers N; Vanrusselt H; Couturier J; Vanoosthuyse A; Kessels S; Lodder C; Brône B; Huaux F; Octave JN; Terwel D; Dewachter I
Acta Neuropathol; 2019 Apr; 137(4):599-617. PubMed ID: 30721409
[TBL] [Abstract][Full Text] [Related]
11. TLR4/Rac1/NLRP3 Pathway Mediates Amyloid-β-Induced Neuroinflammation in Alzheimer's Disease.
Zhu M; Liu Y; Chen C; Chen H; Ni W; Song Y; Lv B; Hua F; Cui G; Zhang Z
J Alzheimers Dis; 2024; 99(3):911-925. PubMed ID: 38728187
[TBL] [Abstract][Full Text] [Related]
12. NLRP3 Inflammasome: A Starring Role in Amyloid-β- and Tau-Driven Pathological Events in Alzheimer's Disease.
Van Zeller M; Dias D; Sebastião AM; Valente CA
J Alzheimers Dis; 2021; 83(3):939-961. PubMed ID: 34366341
[TBL] [Abstract][Full Text] [Related]
13. Amyloid-β activates NLRP3 inflammasomes by affecting microglial immunometabolism through the Syk-AMPK pathway.
Jung ES; Suh K; Han J; Kim H; Kang HS; Choi WS; Mook-Jung I
Aging Cell; 2022 May; 21(5):e13623. PubMed ID: 35474599
[TBL] [Abstract][Full Text] [Related]
14. Myricetin improves pathological changes in 3×Tg-AD mice by regulating the mitochondria-NLRP3 inflammasome-microglia channel by targeting P38 MAPK signaling pathway.
Liu P; Zhou Y; Shi J; Wang F; Yang X; Zheng X; Wang Y; He Y; Xie X; Pang X
Phytomedicine; 2023 Jul; 115():154801. PubMed ID: 37086707
[TBL] [Abstract][Full Text] [Related]
15. NLRP3 Inflammasome Blocking as a Potential Treatment of Central Insulin Resistance in Early-Stage Alzheimer's Disease.
Komleva YK; Potapenko IV; Lopatina OL; Gorina YV; Chernykh A; Khilazheva ED; Salmina AB; Shuvaev AN
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769018
[TBL] [Abstract][Full Text] [Related]
16. Pterostilbene inhibits amyloid-β-induced neuroinflammation in a microglia cell line by inactivating the NLRP3/caspase-1 inflammasome pathway.
Li Q; Chen L; Liu X; Li X; Cao Y; Bai Y; Qi F
J Cell Biochem; 2018 Aug; 119(8):7053-7062. PubMed ID: 29737568
[TBL] [Abstract][Full Text] [Related]
17. Ginkgolide B inhibits NLRP3 inflammasome activation and promotes microglial M2 polarization in Aβ
Zhang Y; Zhao Y; Zhang J; Gao Y; Li S; Chang C; Yu D; Yang G
Neurosci Lett; 2021 Nov; 764():136206. PubMed ID: 34478813
[TBL] [Abstract][Full Text] [Related]
18. Dl-3-n-Butylphthalide Inhibits NLRP3 Inflammasome and Mitigates Alzheimer's-Like Pathology via Nrf2-TXNIP-TrX Axis.
Wang CY; Xu Y; Wang X; Guo C; Wang T; Wang ZY
Antioxid Redox Signal; 2019 Apr; 30(11):1411-1431. PubMed ID: 29634349
[TBL] [Abstract][Full Text] [Related]
19. Pyroptosis in Alzheimer's disease: cell type-specific activation in microglia, astrocytes and neurons.
Moonen S; Koper MJ; Van Schoor E; Schaeverbeke JM; Vandenberghe R; von Arnim CAF; Tousseyn T; De Strooper B; Thal DR
Acta Neuropathol; 2023 Feb; 145(2):175-195. PubMed ID: 36481964
[TBL] [Abstract][Full Text] [Related]
20. Targeting NLRP3-Mediated Neuroinflammation in Alzheimer's Disease Treatment.
Barczuk J; Siwecka N; Lusa W; Rozpędek-Kamińska W; Kucharska E; Majsterek I
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
